Dasatinib N-oxide is a major and N-oxidated metabolite of Dasatinib (BMS354825; Sprycel), which is an approved anticancer drug acting as a dual Bcr-Abl and Src kinase inhibitor. It is also an impurity during the production of dasatinib.